My NCBISign In
Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis
Lisa Carroll, Ian H Frazer, Malcolm Turner, Thomas H Marwick, Ranjeny Thomas
Arthritis Res Ther. 2007; 9(2): R39. Published online 2007 April 11. doi: 10.1186/ar2175
PMCID:
PMC1906817
Abstract Full Text PDF–151K

Is Cited by the Following 2 Articles in this Archive:

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
Yueh-Sheng Chen, Weixing Yan, Carolyn L Geczy, Matthew A Brown, Ranjeny Thomas
Arthritis Res Ther. 2009; 11(2): R39. Published online 2009 March 11. doi: 10.1186/ar2645
PMCID:
PMC2688185
Abstract Full Text PDF–310K
Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation
Suad Hannawi, Brian Haluska, Thomas H Marwick, Ranjeny Thomas
Arthritis Res Ther. 2007; 9(6): R116. Published online 2007 November 6. doi: 10.1186/ar2323
PMCID:
PMC2246234
Abstract Full Text PDF–712K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk